Pleno Inc. has secured $15 million in a pre-series A financing led by Medical Excellence Capital and Alexandria Venture Investments. The proceeds will support development of startup Pleno’s Hypercoding multiomic instrument platform. In conjunction with the financing, Pleno named Gregory Lucier as chairman of its board of directors. Read More
Organ transplant diagnostic company Caredx Inc. has received CE marking for its Alloseq HCT chimerism testing kit and Alloseq HCT interpretation software for use in patients who have received hematopoietic cell transplantation (HCT). The NGS-based solution is used to monitor engraftment and evaluate the success of a hematopoietic stem cell transplant by measuring the relative ratio of the recipient and the donor cell population post-transplantation. Read More
Retispec Inc. and the Toronto Memory Program launched a community screening program for Alzheimer’s disease (AD) funded by the Davos Alzheimer’s Collaborative (DAC). The program will provide two points of entry for screening—optometry clinics and the Alzheimer Society of Toronto. The project is one of 12 early detection efforts worldwide that received a total of $4.5 million in funding this week from DAC. Read More
The mutual recognition agreement between Switzerland and the EU for medical devices lapsed in 2021, a development that was expected to add a significant amount of drag on Swiss device exports to EU nations. Read More
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Aspivix, Iterative Scopes, Castle Biosciences. Read More
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Aalto Bio, Attune Medical, Biosynth Carbosynth, Cardio Diagnostics, Ikonisys, Infandx, Skylinedx, Spectrum Solutions. Read More
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Angle, Centogene, Genomic Testing Cooperative, Hologic, Seekin. Read More